It has been further reported that CLU inhibits lung cancer progression by inhibiting TGFBR1-induced TRAF6/TAB2/TAK1 complex recruitment and thus blocking the TAK1-NF-κB axis [36], indicating its tumor-suppressive function, which is consistent with our in vivo data. Here, NFKB1 is linked to lung cancer.